Does the trade of medical products contribute to promoting human development?-An empirical analysis based on data
Liang Wu1, Wenxia Liu1, Jianhua Zhou1
1School of Economics and Management, Huzhou University, Huzhou, China.
Background:
As the RCEP (Regional Comprehensive Economic Partnership) Agreement deepens, the role of medical product trade in safeguarding regional public health security and promoting economic development has become increasingly prominent.
Methods:
Based on data from 2004 to 2023, this study employs the stochastic frontier gravity model and benchmark regression model to explore the impact of China's medical product export efficiency on the development indices of RCEP countries.
Results:
The findings are as follows: (1) China's medical product exports to RCEP countries exhibit simultaneous scale expansion, structural differentiation, and market concentration, with ASEAN, Japan, and South Korea as core markets and mid-to-low-end products dominating the export structure; (2) Trade efficiency evolution reflects dual mechanisms of institutional environment and technological capabilities, where governance levels and health system soundness optimize efficiency, while excessive liberalization and tax burdens increase friction costs; (3) Enhanced export efficiency indirectly promotes human development in RCEP countries by strengthening basic health service coverage, forming a "trade-health-development" transmission mechanism.
Conclusion:
To enhance export efficiency and achieve synergistic development, we propose: (1) For policymakers: Deepen institutional coordination and establish a "trade-health" collaborative governance framework to amplify public health dividends; (2) For exporters: Implement a tiered market strategy and strengthen technological innovation to enhance industrial resilience.
Related Concept Videos
01:52Regression Toward the Mean
01:12Analysis of Population Pharmacokinetic Data
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
01:26Methods Of Healthcare Delivery System
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
01:23Mechanistic Models: Compartment Models in Individual and Population Analysis
01:12Hazard Ratio
For example, in a clinical trial...